Studies have shown that renal sympathetic denervation appears to significantly improve glucose metabolism in the short term, such as fasting blood glucose control, insulin secretion, C-peptide levels, insulin sensitivity, and glucose tolerance within 3 months, in patients with resistant hypertension (11, 12). This evidence concerns the gene INS and Hypertension resistant to conventional therapy.